Joe Mitchell: ALEC Action Supported Repealing The ACA And Medicaid Expansion And Encouraged State Legislators To Oppose Capping Prescription Drug Prices

ALEC Action Implored Congress To Repeal The ACA And Repeal Medicaid Expansion

ALEC Action: “ALEC Action Encourages Congress To Continue Working Toward A Compromise To Determine Public Policies That Will Repeal And Replace The Affordable Care Act (ACA).” “Since Obamacare was signed into law, Americans have experienced higher cost-sharing, double-digit premium increases and fewer choices in healthcare products and services. Because of this, ALEC Action encourages Congress to continue working toward a compromise to determine public policies that will repeal and replace the Affordable Care Act (ACA). Here are some principles we advocate be a part of this historic legislation: […] Repeal the ACA’s harmful mandates, taxes and fees that have driven up the cost of healthcare. Through the use of stabilization and state innovation funding, a repeal and replace bill should also allow states the authority to create a safety net for their health insurance markets, and provide care for their sickest individuals.” [ALEC Action, accessed 5/27/26]

ALEC Action Supported Repealing Medicaid Expansion. “ALEC Action supports the repeal of Medicaid Expansion, and further, phasing out the disproportionate federal match rate for the Medicaid Expansion population.” [ALEC Action, accessed 5/27/26]

ALEC Action Advocated For Eliminating Price Controls On The Pharmaceutical Industry And Several Other Government Measures To Assist Cost Negotiations With Drug Companies

ALEC Action Headline: “State Legislators: Oppose Anti-Free Market Pharmaceutical Price Control Proposals.” [ALEC Action, accessed 5/27/26]

ALEC Action Opposed Plans To Tie Medication Prices In The U.S. To Other Countries’ Price Ceilings And To Employ International Reference Pricing. “ALEC Action is pleased to present the undersigned members of the American Legislative Exchange Council (ALEC) who oppose plans and legislation that seek to control and limit pharmaceutical prices artificially. […] The current International Pricing Index (IPI) proposal being advanced by HHS would tie prices for medicines in the U.S. to other countries’ price ceilings. Other proposals from Congress would use international reference pricing to accomplish similar goals. An additional idea under consideration would permit prescription drug importation if drugs from foreign countries could be procured at substantial discounts. […] These ideas are well-meaning but misguided attempts to address a real problem.” [ALEC Action, accessed 5/27/26]

  • Brookings: “International Reference Pricing’ (IRP) Is A Method For Aggregating Information About What Other Countries Pay For Drugs To Inform Pricing Choices Within One’s Own Country.” “Around the world, prices for prescription drugs vary. ‘International reference pricing’ (IRP) is a method for aggregating information about what other countries pay for drugs to inform pricing choices within one’s own country. The use of IRP is quite common.” [Brookings, 7/9/25]
  • Brookings: Nearly All EU Member Countries Uses IRP “In The Context Of Negotiations With Pharmaceutical Manufacturers And Not As Direct Price Setting Mechanisms.” “Nearly all member countries of the European Union and most Organization for Economic Co-operation and Development (OECD) countries look to some sort of IRP, generally in the context of negotiations with pharmaceutical manufacturers and not as direct price setting mechanisms.” [Brookings, 7/9/25]

ALEC Action Opposed Importing Drugs From Other Counties, Even If They Could Be Obtained At Discounted Rates. “ALEC Action is pleased to present the undersigned members of the American Legislative Exchange Council (ALEC) who oppose plans and legislation that seek to control and limit pharmaceutical prices artificially. […] The current International Pricing Index (IPI) proposal being advanced by HHS would tie prices for medicines in the U.S. to other countries’ price ceilings. Other proposals from Congress would use international reference pricing to accomplish similar goals. An additional idea under consideration would permit prescription drug importation if drugs from foreign countries could be procured at substantial discounts. […] These ideas are well-meaning but misguided attempts to address a real problem.” [ALEC Action, accessed 5/27/26]

ALEC Action Supported ALEC Model Policy Mandating The Elimination Of Price Controls And Reference Pricing On The Pharmaceutical Industry. “The 2015 Congressional Trade Priorities and Accountability Act, for which ALEC has supporting model policy here, mandates the negotiation of trade frameworks that ‘achieve the elimination of government measures such as price controls and reference pricing which deny full market access for United States products.’ Prioritizing the negotiation of trade agreements that make the lifting of pharmaceutical price controls would be a good place to start.” [ALEC Action, accessed 5/27/26]

Source report (PDF)